- Home
- LSF vs BDSX Comparison
LSF vs BDSX Comparison
Compare LSF & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSF
- BDSX
- Stock Information
- Founded
- LSF 2015
- BDSX 2005
- Country
- LSF United States
- BDSX United States
- Employees
- LSF N/A
- BDSX N/A
- Industry
- LSF Packaged Foods
- BDSX Precision Instruments
- Sector
- LSF Consumer Staples
- BDSX Health Care
- Exchange
- LSF Nasdaq
- BDSX Nasdaq
- Market Cap
- LSF 62.0M
- BDSX 61.9M
- IPO Year
- LSF 2020
- BDSX 2020
- Fundamental
- Price
- LSF $4.92
- BDSX $6.42
- Analyst Decision
- LSF Strong Buy
- BDSX Strong Buy
- Analyst Count
- LSF 2
- BDSX 5
- Target Price
- LSF $12.00
- BDSX $32.50
- AVG Volume (30 Days)
- LSF 26.0K
- BDSX 52.8K
- Earning Date
- LSF 11-05-2025
- BDSX 10-31-2025
- Dividend Yield
- LSF N/A
- BDSX N/A
- EPS Growth
- LSF N/A
- BDSX N/A
- EPS
- LSF N/A
- BDSX N/A
- Revenue
- LSF $47,027,546.00
- BDSX $76,556,000.00
- Revenue This Year
- LSF $21.88
- BDSX $18.80
- Revenue Next Year
- LSF $20.86
- BDSX $27.76
- P/E Ratio
- LSF N/A
- BDSX N/A
- Revenue Growth
- LSF 22.79
- BDSX 25.70
- 52 Week Low
- LSF $4.45
- BDSX $3.44
- 52 Week High
- LSF $10.90
- BDSX $34.40
- Technical
- Relative Strength Index (RSI)
- LSF 29.65
- BDSX 51.28
- Support Level
- LSF $5.00
- BDSX $7.25
- Resistance Level
- LSF $5.43
- BDSX $7.81
- Average True Range (ATR)
- LSF 0.29
- BDSX 0.54
- MACD
- LSF -0.07
- BDSX -0.37
- Stochastic Oscillator
- LSF 7.62
- BDSX 6.42
About LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.